NCT04536012

Brief Summary

A randomized trial of a gamification-enhanced home-based walking program compared with a standard home-based walking program in patients with intermittent claudication. Patients will be provided with a Fitbit device and set an exercise goal. Over the next 16 weeks, patients will receive text message reminders to exercise and daily steps will be tracked. Half of patients will be randomized to a gamified interface that leverages behavioral economic principles to encourage exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
103

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 27, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 2, 2020

Completed
1 month until next milestone

Study Start

First participant enrolled

October 5, 2020

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 14, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

February 4, 2025

Completed
Last Updated

February 4, 2025

Status Verified

January 1, 2025

Enrollment Period

3.1 years

First QC Date

August 27, 2020

Results QC Date

November 5, 2024

Last Update Submit

January 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Daily Step Count

    Change in daily step count from baseline to the intervention period (main adjusted model)

    16 Weeks

Secondary Outcomes (1)

  • Change in Daily Step Count

    24 Weeks

Other Outcomes (3)

  • Change in Walking Impairment Questionnaire Score

    24 Weeks

  • Change in PROMIS Mobility, Pain Interference, and Satisfaction With Social Roles and Activities Scores

    24 Weeks

  • Change in SF-36 Physical Functioning Scale

    24 Weeks

Study Arms (2)

Control

NO INTERVENTION

Via the Way to Health platform, all patients will receive daily text messages that inform them of their previous day's step count for 24 weeks.

Intervention

EXPERIMENTAL

Participants have a 4-week ramp-up towards their step goal and are asked to maintain the goal for the rest of the study. They receive daily texts informing them if they met their step goal and biweekly texts to encourage walking for exercise. Participants are entered into a game. Each week they receive 70 points. If the step goal was met they keep their points. If not, they lose 10 points. At the end of the week if they have at least 40 points they move up a level. If not, they drop a level. Participants start in the middle of 5 levels. Participants choose a support partner who gets a weekly email with the participant's progress. We hold a 3-way phone call with the participant and partner to discuss ways they can help the participant meet their goal. Every 8 weeks, we have a follow up call if the participant is stuck in a lower level and restart them back at the middle level. In the follow-up period, participants continue to get a daily text stating if they met their step goal.

Behavioral: Gamification and Social Incentives

Interventions

Participants in the intervention arm will receive gamification and social incentives as part of the intervention. See arm descriptions for more detail.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years of age
  • Peripheral artery disease, defined as ankle-brachial index \< 0.90, lower extremity CT scan or ultrasound consistent with PAD, angiography with ≥ 70% stenosis in any lower extremity artery, or a history of medical or surgical revascularization
  • Owns a smartphone or tablet operating the iOS or Android operating system

You may not qualify if:

  • Unable or unwilling to provide informed consent, including but not limited to cognitive or language barriers (reading or comprehension)
  • Critical limb ischemia, defined as rest pain, ulceration, or tissue loss involving the lower extremity
  • Planned lower extremity revascularization
  • Prior above or below the knee amputation
  • Require a wheelchair or the use of a walking aid other than a cane
  • Currently participating in a supervised exercise program for patients with PAD
  • Anticipated life expectancy less than 6 months
  • Any other reason why it is not feasible to complete the entire 6-month study
  • Step count \> 7500/day during the baseline data collection period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

Related Publications (2)

  • Fanaroff AC, Coratti S, Farraday D, Norton L, Rareshide C, Zhu J, Levin MG, Damrauer SM, Giri JS, Chokshi NP, Jackson BM, Patel MS. Effect of Gamification Plus Automated Coaching to Increase Physical Activity Among Patients With Peripheral Artery Disease: The GAMEPAD Randomized Controlled Trial. J Am Heart Assoc. 2025 Dec 16;14(24):e038921. doi: 10.1161/JAHA.124.038921. Epub 2025 Dec 3.

  • Fanaroff AC, Coratti S, Farraday D, Norton L, Rareshide C, Zhu J, Levin MG, Damrauer SM, Giri JS, Chokshi NP, Jackson BM, Patel MS. Gamification-augmented home-based exercise for peripheral artery disease: Rationale and design of the GAMEPAD Study. Am Heart J. 2024 Apr;270:95-102. doi: 10.1016/j.ahj.2024.02.003. Epub 2024 Feb 13.

MeSH Terms

Conditions

Peripheral Arterial Disease

Condition Hierarchy (Ancestors)

AtherosclerosisArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesPeripheral Vascular Diseases

Results Point of Contact

Title
Alexander C. Fanaroff, MD, MHS
Organization
Hospital of the University of Pennsylvania

Study Officials

  • Alexander Fanaroff, MD, MHS

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2020

First Posted

September 2, 2020

Study Start

October 5, 2020

Primary Completion

November 14, 2023

Study Completion

January 8, 2024

Last Updated

February 4, 2025

Results First Posted

February 4, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations